Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ma

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Hematotherapy|December 1, 1996
The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study GroupA Chang, D D Ma
The Australasian Journal of Dermatology|August 10, 1999
Acral keratotic graft versus host disease simulating wartsS Kossard, D D Ma
Australian and New Zealand Journal of Medicine|October 1, 1993
Cell adhesion molecules and their role in haemopoiesis and in haematological diseasesN Straetmans, D D Ma
The Medical Journal of Australia|January 24, 1981
Autologous bone marrow transplant in the treatment of malignant diseaseD D Ma, J C Biggs
Australian and New Zealand Journal of Medicine|December 1, 1989
Multidrug resistance and P-glycoprotein expression in human cancerD D Ma, D R Bell
British Journal of Haematology|June 1, 1997
A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutationM R Aboud, D D Ma
Annals of Internal Medicine|January 15, 1994
Antisense oligonucleotide therapies: are they the "magic bullets"?D D Ma, T L Doan
Pathology|October 1, 1992
A method for enriching myeloid (CFU-GM) and erythroid (BFU-E) progenitor cells from human cord blood by accessory cell depletionL A Dowton, D D Ma
Clinical and Laboratory Haematology|February 15, 2002
Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistanceM R Aboud, D D Ma
Acta Haematologica|January 1, 1993
Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemiaC K Arthur, D D Ma
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Hematotherapy|December 1, 1996
The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study GroupA Chang, D D Ma
The Australasian Journal of Dermatology|August 10, 1999
Acral keratotic graft versus host disease simulating wartsS Kossard, D D Ma
Australian and New Zealand Journal of Medicine|October 1, 1993
Cell adhesion molecules and their role in haemopoiesis and in haematological diseasesN Straetmans, D D Ma
The Medical Journal of Australia|January 24, 1981
Autologous bone marrow transplant in the treatment of malignant diseaseD D Ma, J C Biggs
Australian and New Zealand Journal of Medicine|December 1, 1989
Multidrug resistance and P-glycoprotein expression in human cancerD D Ma, D R Bell
British Journal of Haematology|June 1, 1997
A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutationM R Aboud, D D Ma
Annals of Internal Medicine|January 15, 1994
Antisense oligonucleotide therapies: are they the "magic bullets"?D D Ma, T L Doan
Pathology|October 1, 1992
A method for enriching myeloid (CFU-GM) and erythroid (BFU-E) progenitor cells from human cord blood by accessory cell depletionL A Dowton, D D Ma
Clinical and Laboratory Haematology|February 15, 2002
Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistanceM R Aboud, D D Ma
Acta Haematologica|January 1, 1993
Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemiaC K Arthur, D D Ma
Pageof 8